Risk of recurrent ischaemic events in ACS patients with baseline LDL-C below guideline-recommended thresholds: insights from the prospective SPUM-ACS study

被引:0
|
作者
Denegri, A. [1 ]
Kraler, S. [2 ]
Wenzl, F. [2 ]
Raeber, L. [3 ]
Gencer, B. [4 ]
Muller, O. [5 ]
Nanchen, D. [6 ]
Klingenberg, R. [7 ]
Luescher, T. F. [8 ]
机构
[1] Univ Hosp Parma, Parma, Italy
[2] Univ Zurich, Ctr Mol Cardiol, Zurich, Switzerland
[3] Bern Univ Hosp, Cardiol, Bern, Switzerland
[4] Geneva Univ Hosp, Cardiol, Geneva, Switzerland
[5] Univ Hosp Ctr Vaudois CHUV, Lausanne, Switzerland
[6] Ctr Primary Care & Publ Hlth Unisante, Lausanne, Switzerland
[7] Kerckhoff Heart & Thorax Ctr, Bad Nauheim, Germany
[8] Royal Brompton & Harefield Hosp, Harefield, Uxbridge, England
基金
瑞士国家科学基金会;
关键词
D O I
10.1093/eurheartj/ehae666.1539
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 12 条
  • [1] Real-World Risk of Recurrent Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with LDL-C Above Guideline-Recommended Threshold: A Retrospective Observational Study
    Mackinnon, Erin S.
    Leiter, Lawrence A.
    Wani, Rajvi J.
    Burke, Natasha
    Shaw, Eileen
    Witges, Kelcie
    Goodman, Shaun G.
    CARDIOLOGY AND THERAPY, 2024, 13 (01) : 205 - 220
  • [2] Real-World Risk of Recurrent Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with LDL-C Above Guideline-Recommended Threshold: A Retrospective Observational Study
    Erin S. Mackinnon
    Lawrence A. Leiter
    Rajvi J. Wani
    Natasha Burke
    Eileen Shaw
    Kelcie Witges
    Shaun G. Goodman
    Cardiology and Therapy, 2024, 13 : 205 - 220
  • [3] Circulating dipeptidyl peptidase 3 predicts hemodynamic impairment and premature death in acute coronary syndromes: insights from the prospective multicenter SPUM-ACS study
    Wenzl, F. A.
    Kraler, S.
    Raeber, L.
    Muller, O.
    Bergmann, A.
    Bourgeois, K.
    Akhmedov, A.
    Camici, G. G.
    Matter, C. M.
    Von Eckardstein, A.
    Roffi, M.
    Gencer, B.
    Templin, C.
    Luescher, T. F.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [4] Impact of recurrent ischaemic and bleeding events on quality of life in patients with acute coronary syndrome: Insights from the FORCE-ACS registry
    van der Sangen, Niels M. R.
    Azzahhafi, Jaouad
    Yin, Dean R. P. P. Chan Pin
    Rayhi, Senna
    van Weede, Victoria M.
    Walhout, Ronald J.
    Gin, Melvyn Tjon Joe
    Pisters, Ron
    Nicastia, Deborah M.
    Langerveld, Jorina
    Vlachojannis, Georgios J.
    van Bommel, Rutger J.
    Appelman, Yolande
    Henriques, Jose P. S.
    ten Berg, Jurrien
    Kikkert, Wouter
    OPEN HEART, 2023, 10 (02):
  • [5] Achievement of guideline-recommended goals for LDL-C in patients with acute myocardial infarction admitted to Swiss hospitals between 2020 and 2022 and characterization of medication, risk factors and cardiovascular outcomes
    Loosli, Jan
    Foster-Witassek, Fabienne
    Rickli, Hans
    Roffi, Marco
    Pedrazzini, Giovanni
    Eberli, Franz
    Ahmed, Kashan
    Radovanovic, Dragana
    SWISS MEDICAL WEEKLY, 2023, 153 : 42S - 42S
  • [6] ANTIPLATELET THERAPY CHANGES FOR MI PATIENTS WITH RECURRENT ISCHEMIC EVENTS: INSIGHTS INTO CONTEMPORARY PRACTICE FROM THE TRANSLATE-ACS STUDY
    Fanaroff, Alexander C.
    Kaltenbach, Lisa A.
    Peterson, Eric
    Akhter, Mohammed
    Effron, Mark B.
    Henry, Timothy
    Wang, Tracy
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 24 - 24
  • [7] Atherothrombotic residual risk in coronary and peripheral artery disease patients on guideline-recommended antiplatelet monotherapy: baseline preliminary results from the RESRISK study
    Vallejo-Vaz, A.
    Dharmayat, K. I.
    Nzeakor, N.
    Fatoba, S. T.
    McMahon, P.
    Tolani, E.
    Carrasco, C. P.
    Ray, K. K.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2546 - 2546
  • [8] Prescription of statins and one year risk of major clinical outcomes among ACS patients with extremely low LDL-c (<70mg/dl): data from CPACS studies
    Sun, Y. H.
    Xie, G. Q.
    Patel, A.
    Li, S. S.
    Zhao, W.
    Yang, X. Z.
    Tao, W.
    Du, X.
    Hu, R.
    Chen, H.
    Gao, R. L.
    Wu, Y. F.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1166 - 1166
  • [9] Association of Heart Failure Re-Hospitalization Rate With Physicians' and Patients' Adherence to the Guideline-Recommended Therapy: Insights From a Prospective Pragmatic Study Within the Optimize Heart Failure Care Program
    Lopatin, Yuri
    Grebennikova, Anna
    Hamayak, Sisakian
    Hayrapetyan, Hamlet
    Berkinbaev, Salim
    Rakisheva, Amina
    Pagava, Zurab
    Kipiani, Zviad
    Voronkov, Leonid
    Glezer, Maria
    Tseluyko, Vera
    Tarlovskaya, Ekaterina
    Kurlianskaya, Alena
    Chesnikova, Anna
    Abdullaev, Timur
    Koziolova, Natalia
    Dadashova, Gulnaz
    CIRCULATION, 2018, 138
  • [10] Antiplatelet Therapy Changes for Patients With Myocardial Infarction With Recurrent Ischemic Events: Insights Into Contemporary Practice From the TRANSLATE-ACS (Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome) Study
    Fanaroff, Alexander C.
    Kaltenbach, Lisa A.
    Peterson, Eric D.
    Akhter, Mohammed W.
    Effron, Mark B.
    Henry, Timothy D.
    Wang, Tracy Y.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (04):